SEC Form 4 · accession 0001209191-18-024686

GLOBUS MEDICAL INC · GMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior VP and CFO

Period of report

Apr 9, 2018

Accepted (ET)

Apr 11, 2018 · 6:01 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001237831

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Apr 9, 2018	M	18,210	$25.40	A	18,210	D
Class A Common Stock^F2	Apr 9, 2018	S	18,210	$50.0017	D	0	D
Class A Common Stock	Apr 10, 2018	M	50,540	$25.40	A	50,540	D
Class A Common Stock	Apr 10, 2018	S	50,540	$50.00	D	0	D
Class A Common Stock	Apr 10, 2018	M	31,250	$25.52	A	31,250	D
Class A Common Stock	Apr 10, 2018	S	31,250	$50.00	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F3	$25.40	Apr 9, 2018	M	18,210	D	—	Apr 8, 2025	Class A Common Stock	18,210	81,790	D
Stock Option (Right to Buy Class A Common Stock)^F3	$25.40	Apr 10, 2018	M	50,540	D	—	Apr 8, 2025	Class A Common Stock	50,540	31,250	D
Stock Option (Right to Buy Class A Common Stock)^F4	$25.52	Apr 10, 2018	M	31,250	D	—	Jan 25, 2026	Class A Common Stock	31,250	118,750	D

F1This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 9, 2018, which is intended to comply with Rule 10b5-1.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3These options were granted on April 8, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on May 4, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F4These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.